KPIs & Operating Metrics(New)

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Moderna (MRNA) Shares Repurchased (2021 - 2023)

Moderna (MRNA) has disclosed Shares Repurchased for 3 consecutive years, with -$1.0 million as the latest value for Q3 2023.

For Q3 2023, Shares Repurchased fell 100.1% year-over-year to -$1.0 million; the TTM value through Jun 2024 reached -$1.0 million, down 100.04%, while the annual FY2025 figure was $2.0 million, N/A changed from the prior year.
Shares Repurchased hit -$1.0 million in Q3 2023 for Moderna, down from $628.0 million in the prior quarter.
Across five years, Shares Repurchased topped out at $1.3 billion in Q2 2022 and bottomed at -$1.0 million in Q3 2023.
Average Shares Repurchased over 3 years is $667.4 million, with a median of $625.5 million recorded in 2022.
On a YoY basis, Shares Repurchased climbed as much as 15.57% in 2023 and fell as far as 100.1% in 2023.
Moderna's Shares Repurchased stood at $857.0 million in 2021, then plummeted by 53.09% to $402.0 million in 2022, then plummeted by 100.25% to -$1.0 million in 2023.
According to Business Quant data, Shares Repurchased over the past three periods came in at -$1.0 million, $628.0 million, and $526.0 million for Q3 2023, Q2 2023, and Q1 2023 respectively.